Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker TMQ
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Aug 28, 2026 | South32 International Investment Holdings Proprietary Ltd 10% owner | TMQ Trilogy Metals Inc. | Sale | 8.22M | $2.17 | $17.8M Sale | Form 4 ↗ |
| May 8, 2026 | Hensley William L. Iggiagruk Director | TMQ Trilogy Metals Inc. | Sale | 50,000 | $4.44 | $222.0K Sale | Form 4 ↗ |
| Feb 26, 2026 | Hensley William L. Iggiagruk Director | TMQ Trilogy Metals Inc. | Sale | 25,107 | $4.40 | $110.5K Sale | Form 4 ↗ |
| Dec 5, 2025 | Gregory A. Lang Director | TMQ Trilogy Metals Inc. | Sale | 50,000 | $4.77 | $238.5K Sale | Form 4 ↗ |
| Dec 5, 2025 | Gregory A. Lang Director | TMQ Trilogy Metals Inc. | Sale | 20,000 | $4.73 | $94.6K Sale | Form 4 ↗ |
| Oct 16, 2025 | James Gowans Director | TMQ Trilogy Metals Inc. | Sale | 100,000 | $7.50 | $750.0K Sale | Form 4 ↗ |
| Oct 9, 2025 | Janice Stairs Director | TMQ Trilogy Metals Inc. | Sale | 50,613 | $6.56 | $332.0K Sale | Form 4 ↗ |
| Oct 9, 2025 | Gregory A. Lang Director | TMQ Trilogy Metals Inc. | Sale | 100,000 | $6.77 | $677.0K Sale | Form 4 ↗ |
| Oct 9, 2025 | Gregory A. Lang Director | TMQ Trilogy Metals Inc. | Sale | 19,181 | $6.57 | $126.0K Sale | Form 4 ↗ |
| Oct 9, 2025 | Gregory A. Lang Director | TMQ Trilogy Metals Inc. | Sale | 50,000 | $6.53 | $326.5K Sale | Form 4 ↗ |
| Oct 9, 2025 | William Beckwith Hayden Director | TMQ Trilogy Metals Inc. | Sale | 200,000 | $6.61 | $1.3M Sale | Form 4 ↗ |
| Oct 8, 2025 | Hensley William L. Iggiagruk Director | TMQ Trilogy Metals Inc. | Sale | 100,000 | $6.39 | $639.0K Sale | Form 4 ↗ |
| Oct 8, 2025 | Diana J. Walters Director | TMQ Trilogy Metals Inc. | Sale | 100,000 | $7.03 | $703.0K Sale | Form 4 ↗ |
| Oct 8, 2025 | Elaine Sanders VP & CFO | TMQ Trilogy Metals Inc. | Sale | 399,000 | $6.84 | $2.7M Sale | Form 4 ↗ |
| Oct 8, 2025 | Elaine Sanders VP & CFO | TMQ Trilogy Metals Inc. | Sale | 50,599 | $6.91 | $349.6K Sale | Form 4 ↗ |
| Oct 8, 2025 | William Beckwith Hayden Director | TMQ Trilogy Metals Inc. | Sale | 64,294 | $7.06 | $453.9K Sale | Form 4 ↗ |
| Jul 30, 2025 | Hensley William L. Iggiagruk Director | TMQ Trilogy Metals Inc. | Sale | 50,000 | $1.74 | $87.0K Sale | Form 4 ↗ |
17 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:44 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances